Search by
Poster Number

1, 2, 3, 4,
5, 6, 7, 8,
9, 10, 11, 12,
13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73

Click on the Poster to View the Poster Page

All Posters

POSTER 49

Thiamidol (isobutylamido thiazolyl resorcinol): A Highly Specific Human Tyrosinase Inhibitor for the Treatment of Hyperpigmentation...

POSTER 50

Clinical Efficacy of the Human Tyrosinase Inhibitor Thiamidol (isobutylamido thiazolyl resorcinol) in Melasma Dennis Roggenkamp, Adel...

POSTER 51

Clinical Evaluation of the Human Tyrosinase Inhibitor Thiamidol (isobutylamido thiazolyl resorcinol) in Prevention of UVB-induced...

POSTER 52

Effective Reduction of Acne-induced Post-inflammatory Hyperpigmentation with the Human Tyrosinase Inhibitor Thiamidol (isobutylamido...

POSTER 53

Combined Thiamidol and Low-fluence Q-switched Nd:YAG Laser for the Treatment of Facial Hyperpigmentation Vasanop Vachiramon, Kanchana...

POSTER 54

Impact of Treatment Duration on Response Durability: A Post Hoc Analysis of the TRuE-V Long-Term Extension Study of Ruxolitinib Cream in...

POSTER 55

Nemolizumab Long-Term Efficacy and Safety up to 100 Weeks in the OLYMPIA Open-Label Extension Study in Patients with Prurigo Nodularis:...

POSTER 56

Dupilumab Provides Rapid and Continuous Improvement in Prurigo Nodularis Signs and Symptoms Over Time: Results From PRIME/PRIME2 Sonja...

POSTER 57

Integrated Interval Analysis of Clinical Trial Data to Evaluate the Long-Term Safety of Risankizumab in Patients With Psoriatic Disease...

POSTER 58

Safety and Efficacy of Risankizumab in Genital and Scalp Psoriasis in the UnlIMMited Phase 4 Randomized Clinical Trial at Week 16 Eingun...

POSTER 59

Patient preference over other topicals, perception of cream usability, treatment adherence and satisfaction among patients with...

POSTER 60

Impact of calcipotriene and betamethasone dipropionate cream with PAD technology (CAL/BDP PAD cream) on patient symptoms, functioning,...

POSTER 61

Impact of calcipotriene and betamethasone dipropionate cream with PAD technology (CAL/BDP PAD cream) on scalp-PGA success, S-mPASI and...

POSTER 62

Roflumilast Foam 0.3% in Patients With Psoriasis of the Scalp and Body: Improvements in Patient-Reported Outcomes in the ARRECTOR Trial...

POSTER 63

Efficacy and Safety of Brodalumab in Patients With Moderate-to-Severe Plaque Psoriasis and Inadequate Response to Prior Biologics Kim...

POSTER 64

Brodalumab: Seven-Year US Pharmacovigilance Report Mark Lebwohl, John Koo, April Armstrong, Bruce Strober, Amber Blair, Soo Han Yoon,...

POSTER 65

Phase 3 Results From an Innovative Trial Design of Treating Plaque Psoriasis Involving Difficult-to-Treat, High-Impact Sites With...

POSTER 66

Icotrokinra, a Targeted Oral Peptide That Selectively Blocks the Interleukin-23–Receptor, for the Treatment of Moderate-to-Severe Plaque...

POSTER 67

Zasocitinib (TAK-279), An Oral, Allosteric, Selective TYK2 Inhibitor, in Moderate-to-Severe Plaque Psoriasis: Efficacy Analysis by...

POSTER 68

Zasocitinib (TAK-279), aA Oral, Allosteric, Highly Selective TYK2 Inhibitor, Reduced PASI Body Region and Individual Component Scores in...

POSTER 69

Real-World Treatment Patterns in Patients with Psoriasis Receiving Tildrakizumab Compared to Ustekinumab George Han, Lynn Huynh, Enrico...

POSTER 70

Incidence of Psoriatic Arthritis in Biologic-Naïve Psoriasis Patients Achieving National Psoriasis Foundation’s Treat to Target Goals: A...

POSTER 71

Inhibition of Structural Damage Progression with Guselkumab, a Selective IL-23i, in Participants with Active PsA: Results through Week 24...

POSTER 72

Real-World Treatment Patterns and Clinical Conditions of Patients with Basal Cell Carcinoma Who Received Sonidegib or Vismodegib...

Search by Poster Number

1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73